Table 2.
Changes of finger JSD of MCP joints (from thumb to little finger) based on DAS28 remission in RA patients treated with CZP 200 mg plus MTX (*P < 0.01; **P = n. s.)
| Finger joint space distance | Baseline, mean (SD) in mm | Week 52, mean (SD) in mm | Difference | |
|---|---|---|---|---|
| DAS28 ≤ 2.6 | JSD-MCPthumb | 0.150 ± 0.041 | 0.163 ± 0.032 | + 8.7%* |
| JSD-MCPindex finger | 0.154 ± 0.042 | 0.168 ± 0.035 | + 9.1%* | |
| JSD-MCPmiddle finger | 0.160 ± 0.040 | 0.164 ± 0.042 | + 2.5%* | |
| JSD-MCPring finger | 0.157 ± 0.039 | 0.158 ± 0.040 | + 0.6%** | |
| JSD-MCPlittle | 0.147 ± 0.035 | 0.157 ± 0.037 | + 6.8%* | |
| JSD-MCPtotal | 0.153 ± 0.030 | 0.162 ± 0.031 | + 5.9%* | |
| DAS28 > 2.6 | JSD-MCPthumb | 0.143 ± 0.038 | 0.140 ± 0.040 | − 2.0%** |
| JSD-MCPindex finger | 0.153 ± 0.066 | 0.150 ± 0.067 | − 1.9%* | |
| JSD-MCPmiddle finger | 0.148 ± 0.053 | 0.146 ± 0.051 | − 1.4%** | |
| JSD-MCPring finger | 0.146 ± 0.038 | 0.145 ± 0.037 | − 0.6%** | |
| JSD-MCPlittle | 0.137 ± 0.039 | 0.135 ± 0.042 | − 1.5% ** | |
| JSD-MCPtotal | 0.146 ± 0.037 | 0.143 ± 0.037 | − 2.1%** |